XBiotech Inc. Common Stock (XBIT)
Stock · NASDAQ · Health Care
$2.1as of 10/16/2026
Price chart
Active signals
XBIT Signal Track Record
How signals performed across all stocks →What XBIT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | -0.9% | 44% | October 7, 2026 |
| Bollinger Band Breakout | 24 | -7.1% | 38% | October 9, 2026 |
| Bollinger Band BreakdownActive now | 21 | -1.7% | 43% | September 2, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -0.3% | 44% | April 27, 2026 |
| Any 20-session window (baseline) | -2.6% | 40% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About XBIT
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the f…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 87
- Website
- www.xbiotech.com/
Fundamentals
- 1-day range
- $2.13$2.26
- Market cap
- $69.51M
- P/E (trailing)
- —
- P/E (forward)
- 16.62
- EPS (trailing)
- $-1.48
- Dividend yield
- —
- Beta
- 0.73
- Avg. volume
- 42.7K
- Ex-dividend date
- July 15, 2021
- Dividend pay date
- July 23, 2021
How XBiotech Inc. Common Stock Makes Money
Where the revenue actually goes — FY2021 annual results
Source: 10-K filed Mar 15, 2022 · via SEC EDGAR / Finnhub
XBiotech Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- XBITXBiotech Inc. Common Stock$2.12▼ 1.85%Market cap $69.51MP/E —$2.09$3.44
- INOInovio Pharmaceuticals Inc. Common Stock$0.99▼ 4.81%Market cap $69.62MP/E —$0.5632$2.72
- IBIOiBio Inc. Common Stock$0.77▼ 1.28%Market cap $69.05MP/E —$0.7328$3.82
- CTORCitius Oncology Inc. Common Stock$0.768▲ 2.95%Market cap $70.67MP/E —$0.491$2.25
- CLNNClene Inc. Common Stock$3.1▼ 6.34%Market cap $68.24MP/E —$3.24$13.5
- CINGCingulate Inc. Common Stock$4.36▼ 0.68%Market cap $68.02MP/E —$3.16$11.89
- RNTXRein Therapeutics Inc. Common Stock$0.59▼ 6.05%Market cap $67.45MP/E —$0.5401$2.18
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| XBIT XBiotech Inc. Common Stock | $69.51M | — | $2.12 | ▼ 1.85% | $2.09$3.44 |
| INO Inovio Pharmaceuticals Inc. Common Stock | $69.62M | — | $0.99 | ▼ 4.81% | $0.5632$2.72 |
| IBIO iBio Inc. Common Stock | $69.05M | — | $0.77 | ▼ 1.28% | $0.7328$3.82 |
| CTOR Citius Oncology Inc. Common Stock | $70.67M | — | $0.768 | ▲ 2.95% | $0.491$2.25 |
| CLNN Clene Inc. Common Stock | $68.24M | — | $3.1 | ▼ 6.34% | $3.24$13.5 |
| CING Cingulate Inc. Common Stock | $68.02M | — | $4.36 | ▼ 0.68% | $3.16$11.89 |
| RNTX Rein Therapeutics Inc. Common Stock | $67.45M | — | $0.59 | ▼ 6.05% | $0.5401$2.18 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 1.92M
- Total value held
- $4.50M
- Institutional holders
- 35
- Unknown293.1K
- Unknown231.0K
- Unknown201.0K
- Unknown198.5K
- Unknown165.6K
- Unknown105.5K
- Unknown98.4K
- Unknown76.1K
- Unknown73.0K
- Unknown60.1K
See the full, filterable feed with live charts on the MarketWall dashboard.